The National Pharmaceutical Pricing Authority (NPPA), the price regulator for drugs, may announce a price increase for vitamins within a week to resume supply of vitamin by GlaxoSmithKlime and Piramal Life Sciences.
According to industry sources, NPPA, in its formulation committee meeting held on Thursday, has considered an upward price revision of multivitamins. For the last three months, domestic pharmaceutical industry has been seeking higher prices for vitamins due to the increasing cost of imported raw material from China.
